共 108 条
[1]
Block GA(2004)Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2208-2218
[2]
Klassen PS(2011)Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population Nephrol Dial Transplant 26 1948-1955
[3]
Lazarus JM(2006)Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients Kidney Int 70 771-780
[4]
Ofsthun N(2017)KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) Kidney Int Suppl (2011) 7 1-59
[5]
Lowrie EG(2005)Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study J Am Soc Nephrol 16 800-807
[6]
Chertow GM(2004)Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis N Engl J Med 350 1516-1525
[7]
Floege J(2012)Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis N Engl J Med 367 2482-2494
[8]
Kim J(2015)Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis Clin J Am Soc Nephrol 10 90-97
[9]
Ireland E(2016)A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism J Am Soc Nephrol 27 2487-2494
[10]
Chazot C(2005)The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002 J Am Soc Nephrol 16 210-218